Expert Interview
A Second View: Looking into the data from the phase 3 Study 304 trial of Caplyta in patients with Schizophrenia.
Ticker(s): ITCIInstitution: University of Pennsylvania
- Professor of Psychiatry at the Perelman School of Medicine
- Author of more than 400 peer-reviewed publications,; his research interests include genetics, pharmacogenetics and medical treatment of addictions, mood disorders, schizophrenia, and epilepsy
- The Berrettini Lab is currently studying single cell transcriptomics in neurons and glia as potential causative factors in risk for addictions, psychotic illnesses, and mood disorders.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
